In a patient with NSTEMI and an echocardiographic ejection fraction of 40‑45% who lacks dyspnea, orthopnea, pulmonary rales, elevated jugular venous pressure, S3 gallop, rapid weight loss, and did not receive intravenous diuretics, does he meet the clinical criteria for ICD‑10‑CM code I50.21 Acute systolic (congestive) heart failure?

Does This Patient Meet Clinical Criteria for I50.21 (Acute Systolic Heart Failure)?

No, this patient does not meet clinical criteria for I50.21 (Acute systolic congestive heart failure) based on the medical record provided.

Clinical Reasoning

Absence of Heart Failure Syndrome

The 2016 ESC Guidelines define heart failure as a clinical syndrome characterized by typical symptoms (breathlessness, ankle swelling, fatigue) accompanied by signs (elevated JVP, pulmonary crackles, peripheral edema) caused by structural/functional cardiac abnormality 1. This patient's presentation lacks these defining features:

• No dyspnea at rest: Multiple provider notes document "denies SOB," "breathing comfortable," and "no respiratory distress" [@medical record]
• No pulmonary congestion: Serial examinations show "lungs clear to auscultation bilaterally," "normal breath sounds," and "no increased work of breathing" [@medical record]
• No volume overload signs: Documented "no edema" in extremities, no JVD, no hepatomegaly [@medical record]
• No S3 gallop: Cardiovascular exams consistently note "normal heart sounds" [@medical record]

Modified Framingham Criteria Not Met

The denial appropriately references Modified Framingham Criteria, which require either 1 major criterion OR 1 major + 2 minor criteria [@denial letter]. This patient has:

Major criteria present: 0

• No paroxysmal nocturnal dyspnea
• No orthopnea (specifically denied)
• No pulmonary rales
• No elevated JVP
• No S3 gallop
• Chest X-ray shows "unremarkable cardiomediastinal silhouette" with no pulmonary edema [@medical record]

Minor criteria present: 1 (possibly 2)

• Transient tachycardia and dyspnea with exertion on one occasion, but this is clearly attributable to the acute NSTEMI rather than heart failure [@medical record]
• The denial correctly notes these symptoms are explained by the myocardial infarction itself [@denial letter]

Structural Abnormality Without Clinical Syndrome

The echocardiogram showing EF 40-45% with regional wall motion abnormalities represents asymptomatic LV systolic dysfunction secondary to acute ischemia, not acute decompensated heart failure [@medical record]. The 2016 ESC Guidelines explicitly distinguish between asymptomatic structural abnormalities (precursors of HF) and the clinical syndrome of heart failure itself [@1@].

Treatment Pattern Inconsistent with Acute Heart Failure

• No IV diuretics administered: This is standard of care for acute heart failure and their absence is notable [@denial letter]
• No evidence of decongestion therapy: No documentation of fluid removal, weight loss, or diuretic response
• The initiation of guideline-directed medical therapy (GDMT) for chronic heart failure (valsartan, metoprolol, dapagliflozin) represents secondary prevention after NSTEMI with reduced EF, not treatment of acute decompensated heart failure [@medical record]

Context: NSTEMI with New-Onset LV Dysfunction

Research demonstrates that up to 15-34% of NSTEMI patients have concomitant heart failure, which significantly worsens prognosis [@3@, @5@]. However, the presence of reduced ejection fraction alone does not constitute acute heart failure without the clinical syndrome 1. This patient's presentation represents acute coronary syndrome with resultant myocardial dysfunction, appropriately coded as NSTEMI with initiation of chronic HF prevention strategies.

Why the Discharge Diagnosis is Problematic

The discharge summary lists "Acute HFmrEF (EF 45-50%)" with "POA=clinically undetermined" [@medical record]. This coding appears to conflate:

1. Structural finding: Reduced EF from LAD territory ischemia
2. Clinical syndrome: Acute heart failure (which is absent)

The "clinically undetermined" POA status itself suggests diagnostic uncertainty, as the clinical picture does not support acute heart failure present on admission [@medical record].

---

Conclusion Regarding Appeal

An appeal for I50.21 cannot be supported based on the UHDDS criteria. The diagnosis lacks:

• Clinical evaluation confirming acute heart failure syndrome (all provider notes document absence of HF signs/symptoms)
• Therapeutic treatment specific to acute heart failure (no IV diuretics, no decongestion)
• Diagnostic findings of acute decompensation (normal chest X-ray, no BNP documented)

The appropriate coding would reflect NSTEMI with reduced ejection fraction as a complication, with initiation of chronic heart failure prevention therapy, but not acute systolic heart failure as a separate reportable diagnosis [@1